This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Viruses and Human Cancer
Organizer(s): Charles R.M. Bangham, Thomas F. Schulz and Paul M. Lieberman
Date: March 29 - April 03, 2015
Location: Big Sky Resort, Big Sky, MT, USA
Sponsored by Merck & Co., Inc., Regeneron Pharmaceuticals, Inc. and Roche
Summary of Meeting:
In 1970, an authoritative book entitled “Viruses and Cancer” was published by Sir Christopher Andrews, one of the discoverers of influenza virus. On page 135 he wrote “Despite these findings, there is no doubt that as regards the generality of cancers in man, and indeed in other mammals, there is no direct evidence that viruses are concerned”. It is now estimated that about 20% of human cancers are caused by infectious agents, among them at least 7 viruses. The increasing appreciation of the role of viruses in cancer pathogenesis has not only already led to the development of two successful vaccines (against HBV and HPV) that prevent cancer, it has also directly contributed to many fundamental discoveries in cancer biology. In the last decade the understanding of virus-induced cancers has been accelerated by the extraordinary developments in genomics, epigenetics and RNA biology. To review this rapidly burgeoning field, this multidisciplinary symposium brings together experts in virology, oncology, immunology, genomics and genetics. The objective of the symposium is to explore how advances in cancer biology can inform the understanding of virus-induced cancers, and how viruses continue to reveal fundamental principles in cancer. Particular emphasis will be laid on the interaction between virus and host in persistent infections by oncogenic viruses. The meeting will cover examples of cancers where a viral cause is still under debate and the rapid development of technology for the detection of unknown viruses.
Scholarship Deadline: December 2 2014
Discounted Abstract Deadline: December 2 2014
Abstract Deadline: January 6 2015
Discounted Registration Deadline: January 27 2015
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Merck & Co., Inc.Regeneron Pharmaceuticals, Inc.Roche
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Novartis Institutes for BioMedical Research
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA192463-01
Funding for this conference was made possible (in part) by 1R13CA192463-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found